FDA approves BTG's varicose vein product

BTG plc (LSE:BTG) jumped 63.10p (14%) to 522p on Tuesday after FDA approved an NDA from the company for Varithena (formerly known as Varisolve) to treat varicose veins. BTG plans to launch the polidoc...